Revolution Medicines

Forecast & Rating25 analysts currently cover Revolution Medicines, with about 96.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $257.80, about 44.9% upside from the current price of $177.96. Price targets range from $179.00 to $320.00 — a wide spread, showing clear disagreement over just how much Revolution Medicines can rise. Historically, about 84.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Revolution Medicines closely still see room for the stock to rise. Data as of Oct 16, 2026; for reference only and not investment advice.